Chagas Disease: Current View of an Ancient and Global Chemotherapy Challenge

被引:23
作者
Martin-Escolano, Javier [1 ]
Medina-Carmona, Encarnacion [2 ]
Martin-Escolano, Ruben [1 ]
机构
[1] Univ Granada, Inst Invest Biosanitaria Ibs Granada, Dept Parasitol, Hosp Univ Granada, Granada 18071, Spain
[2] Univ Granada, Dept Phys Chem, Granada 18071, Spain
来源
ACS INFECTIOUS DISEASES | 2020年 / 6卷 / 11期
关键词
American trypanosomiasis; Chagas disease; chemotherapy; drug discovery; neglected tropical disease; screening cascade; target product profile; Trypanosoma cruzi; TRYPANOSOMA-CRUZI INFECTIONS; DISCRETE TYPING UNITS; IN-VITRO; GENETIC EXCHANGE; DRUG DISCOVERY; NUCLEOTIDE-SEQUENCES; BRAZILIAN CONSENSUS; RANDOMIZED-TRIAL; ADIPOSE-TISSUE; HEART-DISEASE;
D O I
10.1021/acsinfecdis.0c00353
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Chagas disease is a neglected tropical disease and a global public health issue. In terms of treatment, no progress has been made since the 1960s, when benznidazole and nifurtimox, two obsolete drugs still prescribed, were used to treat this disease. Hence, currently, there are no effective treatments available to tackle Chagas disease. Over the past 20 years, there has been an increasing interest in the disease. However, parasite genetic diversity, drug resistance, tropism, and complex life cycle, along with the limited understanding of the disease and inadequate methodologies and strategies, have resulted in the absence of new insights in drugs development and disappointing outcomes in clinical trials so far. In summary, new drugs are urgently needed. This Review considers the relevant aspects related to the lack of drugs for Chagas disease, resumes the advances in tools for drug discovery, and discusses the main features to be taken into account to develop new effective drugs.
引用
收藏
页码:2830 / 2843
页数:14
相关论文
共 129 条
  • [1] Discovery of novel polyamine analogs with anti-protozoal activity by computer guided drug repositioning
    Alberca, Lucas N.
    Sbaraglini, Maria L.
    Balcazar, Dario
    Fraccaroli, Laura
    Carrillo, Carolina
    Medeiros, Andrea
    Benitez, Diego
    Comini, Marcelo
    Talevi, Alan
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2016, 30 (04) : 305 - 321
  • [2] [Anonymous], 2012, Technical report series
  • [3] [Anonymous], DNDI R D PORTF
  • [4] [Anonymous], DRUG TRIAL LEAD PAR
  • [5] [Anonymous], DIS PROJ CHAG DIS
  • [6] Reconsideration of the seven discrete typing units within the species Trypanosoma cruzi, a new proposal of three reliable mitochondrial clades
    Barnabe, Christian
    Mobarec, Hugo Ignacio
    Jurado, Marcelo Roman
    Cortez, Jacqueline Andrea
    Breniere, Simone Frederique
    [J]. INFECTION GENETICS AND EVOLUTION, 2016, 39 : 176 - 186
  • [7] Protozoan persister-like cells and drug treatment failure
    Barrett, Michael P.
    Kyle, Dennis E.
    Sibley, L. David
    Radke, Joshua B.
    Tarleton, Rick L.
    [J]. NATURE REVIEWS MICROBIOLOGY, 2019, 17 (10) : 607 - 620
  • [8] Bern C, 2015, NEW ENGL J MED, V373, P456, DOI [10.1056/NEJMra1410150, 10.1056/NEJMc1510996]
  • [9] Brener Z, 1976, Rev Inst Med Trop Sao Paulo, V18, P450
  • [10] Identification of six Trypanosoma cruzi lineages by sequence-characterised amplified region markers
    Brisse, S
    Dujardin, JC
    Tibayrenc, M
    [J]. MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2000, 111 (01) : 95 - 105